Publications

Export 29 results:
Auteur Title Type [ Année(Asc)]
Filtres: Auteur is Plitman, Eric  [Enlever les filtres]
2019
Takamiya A, Plitman E, Chung JKu, Chakravarty MM, Graff-Guerrero A, Mimura M, Kishimoto T.  2019.  Acute and long-term effects of electroconvulsive therapy on human dentate gyrus.. Neuropsychopharmacology.
Copersino ML, Patel R, Price JS, Visser KFrost, Vitaliano G, Plitman E, Lukas SE, Weiss RD, Janes AC, Chakravarty MM.  2019.  Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry.. Drug Alcohol Depend. :107728.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
Kim J, Plitman E, Iwata Y, Nakajima S, Mar W, Patel R, Chavez S, Chung JKu, Caravaggio F, Chakravarty MM et al..  2019.  Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders.. Prog Neuropsychopharmacol Biol Psychiatry. :109839.
Wada M, Kurose S, Miyazaki T, Nakajima S, Masuda F, Mimura Y, Nishida H, Ogyu K, Tsugawa S, Mashima Y et al..  2019.  The P300 event-related potential in bipolar disorder: A systematic review and meta-analysis.. J Affect Disord. 256:234-249.
Guma E, Plitman E, Chakravarty MM.  2019.  The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia.. Neurosci Biobehav Rev. 104:141-157.
Plitman E, Guma E, Lepage M, Near J, Chakravarty MM.  2019.  Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.. Schizophr Res. 210:13-20.
2017
Winterburn JL, Voineskos AN, Devenyi GA, Plitman E, de la Fuente-Sandoval C, Bhagwat N, Graff-Guerrero A, Knight J, Chakravarty MM.  2017.  Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study. Schizophr Res.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Shinagawa S, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Patel R et al..  2017.  The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.. J Alzheimers Dis. 60(2):341-347.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Shinagawa S, Patel R et al..  2017.  Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.. J Alzheimers Dis. 58(3):747-762.
Caravaggio F, Gerretsen P, Mar W, Chung JKu, Plitman E, Nakajima S, Kim J, Iwata Y, Patel R, Chakravarty MM et al..  2017.  Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.. Psychoneuroendocrinology. 81:80-87.
Plitman E, Iwata Y, Caravaggio F, Nakajima S, Chung JKu, Gerretsen P, Kim J, Takeuchi H, Chakravarty MM, Remington G et al..  2017.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.. Schizophr Bull.
Caravaggio F, Chung JKu, Plitman E, Boileau I, Gerretsen P, Kim J, Iwata Y, Patel R, Chakravarty MM, Remington G et al..  2017.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.. Hum Brain Mapp. 38(11):5519-5534.
Caravaggio F, Plitman E, Chung JKu, Gerretsen P, Kim J, Iwata Y, Chakravarty MM, Remington G, Graff-Guerrero A.  2017.  Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females.. Eur J Neurosci. 46(7):2253-2264.

Pages